Dronabinol is pure tetrahydrocannabinol (THC) and registered as an active pharmaceutical ingredient (API) and registered with the relevant authorities in. approved for sale Germany. Doctors and pharmacists can find more information about the product or how to order on the AMP website: https://amp-eu.com/doccheck-login/
AMP and Eurox have entered into a non-exclusive marketing and distribution agreement for dronabinol for sale in pharmacies from the beginning of 2019 February 2022. In preparation for the start of sales in pharmacies, AMP has trained its national sales team on the benefits of dronabinol for patients for doctors and preparation methods for pharmacists.
Eurox was one of the first medical cannabis companies to make dronabinol made in Germany at one of Europe largest GMP facility in Hessen, Germany and controls the entire supply chain from cultivation through production to sales in order to guarantee stable and efficient delivery to its customers.
Neil Smith, commented the chairman of Eurox: “If you think of the ‘Made in Germany‘, then it’s called Eurox. AMP’s focus on caring for German patients and its national sales coverage make them a perfect partner for us. “
DR. Stefan Feuerstein, President and Director of Greenrise Global and Managing Director of AMP, “The German market is moving towards pharmaceutical products as health authorities tighten their regulatory controls to ensure patient safety. Dronabinol is an established product in Germany, and we expect it to be one of our top-selling products this year. “
About Eurox Pharma
Eurox Pharma is one of Europe leading medical cannabis company. Eurox is vertically integrated, with:
- 100% German subsidiaries responsible for product development and holding intellectual property.
- EU GMP production in Germany together with a German pharmaceutical partner.
- A cultivation facility in Portugal to ensure vertical integration and delivery independence.
- A significant minority stake in Integro Medical Clinics, a UK registered medical cannabis clinic.
- Various top-class sales partnerships in Germany and other European countries & our own sales team.
You can find more information about Eurox at www.eurox-pharma.com
About Greenrise Global Brands
Greenrise Global helps people to recognize the positive properties of cannabis. Greenrise Global is a Canadian publicly traded company with two German subsidiaries: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD wellness company based in Hamburg, with brands like Herbify and CANAVEX® in his portfolio.
AMP, based in Erfurt, supplies pharmacies throughout Erfurt with medical cannabis products Germany, including medical cannabis brands from Aphria, Bedrocan, Little Green Pharma and AMP’s branded product line, and is sold through the nationwide sales team. AMP complies with the German Narcotics Act (BtMG) and the regulatory requirements of the Free State of Thuringia and ensures that products are imported and sold from all over the world Germany meet the standard of good manufacturing practice (EU-GMP) of the European Union.
More information about Greenrise Global can be found at https://greenriseglobal.com/
FOLLOW US ON:
Neither the CSE nor its regulatory service provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this press release.
This press release contains forward-looking statements based on the company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including its business plans and milestones and their timing. Although the company believes that the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements do not guarantee future performance and involve risks and uncertainties that are difficult to control or predict. As a result, actual results and results could differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to publicly update them to reflect new information or the occurrence of future events or circumstances, except as required by law.
SOURCE Greenrise Global Brands Inc.
For further information: GREENRISE CONTACT: Hendrik Knopp, Director, [email protected], +1 236-833-1602; Media inquiries: Valeria Bravo, corporate and media communications, [email protected], +1 604-689-7533; AMP CONTACT: Dr. Stefan Feuerstein, President, Greenrise Global Inc., Managing Director, AMP Alternative Medical Products GmbH, [email protected], +49 151 7284 4643; EUROX CONTACT: Jessica Smith, International PR and Marketing Director, [email protected]